Back to LCTX
Frank, Rimerman Advisors LLC → LCTX
Frank, Rimerman Advisors LLC LCTX Position History
Lineage Cell Therapeutics, Inc.
Quarters held
2
Latest value
$272K
Q3 2026
Peak value
$330K
First seen
Q2 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2026 | $330K |
| Q3 2026 | $272K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $272K | 8.0K | — | — |
| Q2 2026 | $330K | 7.6K | — | — |
Other funds holding LCTX
$537.7M
$391.7M
$332.9M
$299.1M
$259.1M
$242.5M
$238.9M
$219.8M